مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

380
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

165
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

1

Information Journal Paper

Title

LOW PREVALENCE OF HIGH-DOSE METHOTREXATE NEPHROPATHY IN PATIENTS WITH MALIGNANCY

Pages

  105-109

Abstract

 Introduction: METHOTREXATE is an antifolate medication frequently used in the treatment of malignant and nonmalignant diseases. The usage of high-dose METHOTREXATE was limited to patients with osteosarcoma, Ewing sarcoma, lymphoma, and acute lymphoblastic leukemia. One of the major side effects of high-dose METHOTREXATE is nephropathy. The aim of present study was to determine the renal side effects of high-dose METHOTREXATE in patients with malignancies.Materials and Methods: In a study of 102 patients with osteosarcoma (n=72), Ewing sarcoma (n=15), and lymphoma (n=15), treated with high-dose METHOTREXATE, clinical and laboratory data including kidney function tests were recorded at baseline and during followup visits. The mean duration of follow-up was 6 months.Results: The mean age of the patients was 19.5 years (range, 5 to 80 years). The total courses of METHOTREXATE therapy were 273 (median, 2.67 per patient). The mean creatinine level was 0.82 mg/dL. Of the 102 patients, 3 (2.9%) developed ACUTE KIDNEY INJURY with an at risk phase. Another patient (1.0%) developed ACUTE KIDNEY INJURY and its phase was injury according to the RIFLE criteria. None of the cases were failed and ACUTE KIDNEY INJURY was alleviated in all of the affected patients.Conclusions: Our data revealed a low prevalence of ACUTE KIDNEY INJURY with high-dose METHOTREXATE therapy. In addition, these toxicities were limited to the first and second phases of the RIFLE classification, all of which resolved spontaneously.

Cites

References

  • No record.

    • Cite

    APA: Copy

    MASHHADI, MOHAMMAD ALI, KAYKHAEI, MAHMOUD ALI, & SANADGOL, HOUSHANG. (2012). LOW PREVALENCE OF HIGH-DOSE METHOTREXATE NEPHROPATHY IN PATIENTS WITH MALIGNANCY. IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD), 6(2), 105-109. SID. https://sid.ir/paper/309188/en

    Vancouver: Copy

    MASHHADI MOHAMMAD ALI, KAYKHAEI MAHMOUD ALI, SANADGOL HOUSHANG. LOW PREVALENCE OF HIGH-DOSE METHOTREXATE NEPHROPATHY IN PATIENTS WITH MALIGNANCY. IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD)[Internet]. 2012;6(2):105-109. Available from: https://sid.ir/paper/309188/en

    IEEE: Copy

    MOHAMMAD ALI MASHHADI, MAHMOUD ALI KAYKHAEI, and HOUSHANG SANADGOL, “LOW PREVALENCE OF HIGH-DOSE METHOTREXATE NEPHROPATHY IN PATIENTS WITH MALIGNANCY,” IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD), vol. 6, no. 2, pp. 105–109, 2012, [Online]. Available: https://sid.ir/paper/309188/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button